裹住
发表于 2025-3-25 06:41:48
Role of Dyslipidemia in Atherosclerosisines and chemokines (TNF-α, IL-1β, IL-6, MCP-1), and millions of different antigens. This makes the development of atherosclerosis very challenging. In addition to the development of myocardial infarctions, atherosclerosis is also associated with peripheral artery disease. This pathological conditio
晚间
发表于 2025-3-25 08:33:53
Effects of Dyslipidemia on the Cerebral Vesselsscle cells, and their debris are cumulated under the endothelial cell lining. Then, the cumulated products form lipid cores, and these eventually form atheromatous plaques. High blood cholesterol, excluding HDL, eventually causes arteriosclerosis of blood vessels to narrow the diameter of the vessel
专横
发表于 2025-3-25 12:25:31
Impact of Dyslipidemia on Ischemic Stroke-scale clinical trials in stroke patients..Triglyceride (TG) level is high in many clinical situations and has influenced adverse cardiovascular diseases. Despite managing LDL-C adequately, residual risks still remain. Therefore, we must closely observe TGs for patients who are at high risk of ather
残酷的地方
发表于 2025-3-25 19:38:07
Dyslipidemia and Hemorrhagic Stroke in primary stroke prevention. In secondary stroke prevention, the risk of ICH showed a nonsignificant trend for statin therapy and was significantly associated with lipid-lowering therapy. The risk of ICH from statin or lipid-lowering therapy is offset by the prevention of ischemic stroke and subst
STAT
发表于 2025-3-25 23:09:45
Clinical Biomarkers of Dyslipidemiarly prediction and drug development. Here, we reviewed the use of nontraditional lipid biomarkers including apolipoproteins and lipid peroxidation and discussed the role of metabolomics and lipidomics in improving stroke risk evaluation and monitoring the drug effects.
弯腰
发表于 2025-3-26 03:51:10
http://reply.papertrans.cn/88/8798/879759/879759_26.png
FLIC
发表于 2025-3-26 04:36:18
Statinsding Rosuvastatin, Atorvastatin, Simvastatin, Fluvastatin, Pravastatin, Lovastatin, and Pitavastatin. The key pharmacological properties of each statin are slightly different according to their solubility and chemical features. As for their implications on stroke trials, the association between pre-
Hemodialysis
发表于 2025-3-26 11:06:12
Ezetimibelowering effects of ezetimibe, many clinicians are still not convinced of the clinical benefits of ezetimibe. This chapter aims to elucidate the developmental history, pharmacokinetic profiles, mechanisms of action, therapeutic adjustment for practical use, and clinical trial data that may support t
instate
发表于 2025-3-26 13:19:00
Fibrate and Niacin based on clinical trials. Also, recent studies have shown neutral results in that the application of combined niacin and statins can prevent stroke and cardiovascular diseases. Hence, in the future, the effect of fibrates and niacin in decreasing the residual risk of stroke and cardiovascular disea
树上结蜜糖
发表于 2025-3-26 17:39:52
http://reply.papertrans.cn/88/8798/879759/879759_30.png